BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24762510)

  • 1. Lambda light chain myeloma presenting as nodular hepatic lesion: a clinical rarity.
    Pal S; Chattopadhyay B; Chatterjee A; Bhattacharya B
    J Cancer Res Ther; 2014; 10(1):191-3. PubMed ID: 24762510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Lambda light chain myeloma presenting as nodular hepatic lesion: A clinical rarity.
    Ulusan S; Koçer NE
    J Cancer Res Ther; 2015; 11(4):1045. PubMed ID: 26881682
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma presenting as hepatic nodular lesion.
    de Vos M; Druez P; Nicaise M; Ngendahayo P; Sinapi I; Mineur P
    Acta Clin Belg; 2012; 67(5):378-80. PubMed ID: 23189550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
    Bianchi G; Richardson PG; Anderson KC
    J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic hilus extramedullary plasmacytoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) biopsy in a relapsed multiple myeloma].
    Oyama N; Ise M; Mimura N; Tsujimura H; Sakai C; Kumagai K
    Rinsho Ketsueki; 2009 Feb; 50(2):102-6. PubMed ID: 19265303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.
    Dejoie T; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H
    Haematologica; 2016 Mar; 101(3):356-62. PubMed ID: 26635032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diplopia and variable ptosis as the sole initial findings in a case of orbital plasmacytoma and multiple myeloma.
    Galea M; McMillan N; Weir C
    Semin Ophthalmol; 2015 May; 30(3):235-7. PubMed ID: 24164055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple bulky cutaneous plasmacytomas with CNS relapse without bone marrow involvement during the course of a lambda light chain myeloma.
    Serefhanoglu S; Haznedaroglu IC; Goker H; Buyukasik Y; Ozcebe OI
    Onkologie; 2009 Nov; 32(11):662-4. PubMed ID: 19887870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma presenting as plasmacytoma of the base of the skull.
    Alegre A; Tomás JF; Pinilla I; Gil-Fernández JJ; Fernández-Rañada JM
    Am J Hematol; 1996 May; 52(1):60-1. PubMed ID: 8638614
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic cutaneous plasmacytoma: a case report associated with IgA lambda multiple myeloma and a review of the literature of metastatic cutaneous plasmacytomas associated with multiple myeloma and primary cutaneous plasmacytomas.
    Kato N; Kimura K; Yasukawa K; Aikawa K
    J Dermatol; 1999 Sep; 26(9):587-94. PubMed ID: 10535253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
    Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
    Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma presenting as plasmacytoma of the jaws showing prominent bone formation during chemotherapy.
    An SY; An CH; Choi KS; Heo MS
    Dentomaxillofac Radiol; 2013; 42(4):20110143. PubMed ID: 23520399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subglottic extramedullary plasmacytoma with light chain multiple myeloma masquerading as adult-onset asthma.
    Gan YJ; Chopra A; Kanagalingam J
    J Voice; 2014 May; 28(3):394.e1-4. PubMed ID: 24491498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis between bone relapse of breast cancer and lambda light chain multiple myeloma: role of the clinical biochemist.
    Mastroianni A; Panella R; Morelli D
    Tumori; 2019 Dec; 105(6):NP17-NP19. PubMed ID: 30799772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cell lesions of the thyroid: report of a case of solitary plasmacytoma and a review of the literature.
    Kovacs CS; Mant MJ; Nguyen GK; Ginsberg J
    Thyroid; 1994; 4(1):65-71. PubMed ID: 8054863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of hepatic plasmacytoma: a case report.
    Nguyen BD; Dash N; Lupetin AR
    Clin Imaging; 1992; 16(2):98-101. PubMed ID: 1547483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoglobulin D lambda multiple myeloma: a case report].
    Qiao SK; Zhang XJ; Wang FX; Pan L; Yao L; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):643-6. PubMed ID: 17605885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe abdominal pain and diarrhea - unusual multiple myeloma presentation with a severe prognosis: a case report.
    Salguero DA; Barletta PA; Sierraalta W
    J Med Case Rep; 2018 Mar; 12(1):70. PubMed ID: 29549883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic plasmacytosis as a manifestation of relapse in multiple myeloma treated with thalidomide.
    del Giglio A; Weinschenker P; Manhani AR; Carbonell AL; Mitteldorf CA
    South Med J; 2005 Feb; 98(2):238-40. PubMed ID: 15759959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma].
    Maruyama Y; Hayashi T; Ikeda H; Yasui H; Ishida T; Shinomura Y
    Rinsho Ketsueki; 2013 Jan; 54(1):122-6. PubMed ID: 23391656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.